Michael D. Lubeck

3.1k total citations
49 papers, 2.4k citations indexed

About

Michael D. Lubeck is a scholar working on Molecular Biology, Genetics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Michael D. Lubeck has authored 49 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 22 papers in Genetics and 19 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Michael D. Lubeck's work include Virus-based gene therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Glycosylation and Glycoproteins Research (14 papers). Michael D. Lubeck is often cited by papers focused on Virus-based gene therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (19 papers) and Glycosylation and Glycoproteins Research (14 papers). Michael D. Lubeck collaborates with scholars based in United States, Canada and Russia. Michael D. Lubeck's co-authors include Hilary Koprowski, Zenon Steplewski, Walter Gerhard, Peter Palese, Jerome L. Schulman, Dorothee Herlyn, Satoshi Mizutani, Henry F. Sears, P.P. Hung and Bheem M. Bhat and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Michael D. Lubeck

49 papers receiving 2.2k citations

Peers

Michael D. Lubeck
M Sarmiento United States
DAVID O. WHITE Australia
Mark Throsby Netherlands
Oleksandr Kalyuzhniy United States
M Lieberman United States
Heidi Diggelmann Switzerland
Falko G. Falkner Austria
Glenn Ishioka United States
Ronald Vogels Netherlands
Nava Sarver United States
M Sarmiento United States
Michael D. Lubeck
Citations per year, relative to Michael D. Lubeck Michael D. Lubeck (= 1×) peers M Sarmiento

Countries citing papers authored by Michael D. Lubeck

Since Specialization
Citations

This map shows the geographic impact of Michael D. Lubeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Lubeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Lubeck more than expected).

Fields of papers citing papers by Michael D. Lubeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael D. Lubeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Lubeck. The network helps show where Michael D. Lubeck may publish in the future.

Co-authorship network of co-authors of Michael D. Lubeck

This figure shows the co-authorship network connecting the top 25 collaborators of Michael D. Lubeck. A scholar is included among the top collaborators of Michael D. Lubeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael D. Lubeck. Michael D. Lubeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalams, Spyros A., Scott Parker, Xia Jin, et al.. (2012). Safety and Immunogenicity of an HIV-1 Gag DNA Vaccine with or without IL-12 and/or IL-15 Plasmid Cytokine Adjuvant in Healthy, HIV-1 Uninfected Adults. PLoS ONE. 7(1). e29231–e29231. 90 indexed citations
2.
Lubeck, Michael D., С. А. Булат, Irina A. Alekhina, & Elke Lieckfeldt. (2004). Delineation of species within the complex by UP-PCR cross-blot hybridization. FEMS Microbiology Letters. 237(2). 255–260. 7 indexed citations
3.
Chengalvala, Murty, Ramesh A. Bhat, Bheem M. Bhat, S. K. Vernon, & Michael D. Lubeck. (1999). Enhanced immunogenicity of hepatitis B surface antigen by insertion of a helper T cell epitope from tetanus toxoid. Vaccine. 17(9-10). 1035–1041. 14 indexed citations
4.
Chengalvala, Murty, Bheem M. Bhat, Ramesh A. Bhat, et al.. (1997). Replication and immunogenicity of Ad7-, Ad4-, and Ad5-hepatitis B virus surface antigen recombinants, with or without a portion of E3 region, in chimpanzees. Vaccine. 15(3). 335–339. 15 indexed citations
5.
Lubeck, Michael D., Robert J. Natuk, Murty Chengalvala, et al.. (1994). Immunogenicity of Recombinant Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees Following Intranasal Administration. AIDS Research and Human Retroviruses. 10(11). 1443–1449. 64 indexed citations
6.
Lubeck, Michael D., Bheem M. Bhat, Ramesh A. Bhat, et al.. (1994). Efficacy of adenovirus-vectored respiratory syncytial virus vaccines in a new ferret model. Vaccine. 12(7). 607–612. 39 indexed citations
7.
Natuk, Robert J., Michael D. Lubeck, Pranab K. Chanda, et al.. (1993). Immunogenicity of Recombinant Human Adenovirus-Human Immunodeficiency Virus Vaccines in Chimpanzees. AIDS Research and Human Retroviruses. 9(5). 395–404. 56 indexed citations
8.
Lubeck, Michael D., Alan R. Davis, Ramesh A. Bhat, et al.. (1992). Immunogenicity of Recombinant Adenovirus-Respiratory Syncytial Virus Vaccines with Adenovirus Types 4, 5, and 7 Vectors in Dogs and a Chimpanzee. The Journal of Infectious Diseases. 166(4). 769–775. 61 indexed citations
9.
Tacket, Carol O., Genevieve A. Losonsky, Michael D. Lubeck, et al.. (1992). Initial safety and immunogenicity studies of an oral recombinant adenohepatitis B vaccine. Vaccine. 10(10). 673–676. 43 indexed citations
10.
Mason, B B, Murty Chengalvala, Sheau‐Mei Cheng, et al.. (1991). Co-expression of hepatitis B virus antigens by a non-defective adenovirus vaccine vector. Archives of Virology. 118(1-2). 11–27. 11 indexed citations
11.
Chengalvala, Murty, Michael D. Lubeck, Robert J. Natuk, et al.. (1991). Adenovirus vectors for gene expression. Current Opinion in Biotechnology. 2(5). 718–722. 14 indexed citations
12.
Chengalvala, Murty, et al.. (1991). Evaluation of adenovirus type 4 and type 7 recombinant hepatitis B vaccines in dogs. Vaccine. 9(7). 485–490. 33 indexed citations
13.
Steplewski, Zenon, Magdalena Blaszczyk‐Thurin, Michael D. Lubeck, et al.. (1990). Oligosaccharide Y Specific Monoclonal Antibody and Its Isotype Switch Variants. Hybridoma. 9(2). 201–210. 23 indexed citations
14.
Chanda, Pranab K., Robert J. Natuk, Surendra K. Dheer, et al.. (1990). Helper Independent Recombinant Adenovirus Vectors: Expression of HIV env or HBV Surface Antigen. International Reviews of Immunology. 7(1). 67–77. 6 indexed citations
15.
Mason, B B, Alan R. Davis, Murty Chengalvala, et al.. (1990). Adenovirus vaccine vectors expressing hepatitis B surface antigen: Importance of regulatory elements in the adenovirus major late intron. Virology. 177(2). 452–461. 31 indexed citations
16.
17.
Lubeck, Michael D., et al.. (1988). Killing of human tumor cell lines by human monocytes and murine monoclonal antibodies. Cellular Immunology. 111(1). 107–117. 18 indexed citations
18.
Hjorth, Rune, et al.. (1988). A new hamster model for adenoviral vaccination. Archives of Virology. 100(3-4). 279–283. 37 indexed citations
19.
Herlyn, Dorothee, Henry F. Sears, Dimitrios Iliopoulos, et al.. (1986). Anti-idiotypic antibodies to monoclonal antibody CO17-1A.. PubMed. 5 Suppl 1(34). 21–8. 33 indexed citations
20.
Lubeck, Michael D. & F. Brent Johnson. (1976). Multiplication of bovine parvovirus in two cell strains. Infection and Immunity. 13(4). 1289–1292. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M Sarmiento Breakdown of academic impact, for papers by DAVID O. WHITE Breakdown of academic impact, for papers by Mark Throsby Breakdown of academic impact, for papers by Oleksandr Kalyuzhniy Breakdown of academic impact, for papers by M Lieberman Breakdown of academic impact, for papers by Heidi Diggelmann Breakdown of academic impact, for papers by Falko G. Falkner Breakdown of academic impact, for papers by Glenn Ishioka Breakdown of academic impact, for papers by Ronald Vogels Breakdown of academic impact, for papers by Nava Sarver
Rankless by CCL
2026